Agilent Technologies Inc vs Shell PLC — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while Shell PLC trades at $90.55 (market cap $245.77B). The key difference: Shell PLC is far larger — about 5.9× Agilent Technologies Inc's market cap, and Shell PLC pays the higher dividend (3.47%). Which is the better fit depends on your goals.
| A | SHEL | |
|---|---|---|
Market Cap | $42.00B | $245.77B |
Sector | Health | Energy |
52-Week High | $157.20 | $94.15 |
52-Week Low | $110.24 | $70.31 |
Enterprise Value | $43.55B | $287.47B |
Dividend Yield | 0.69% | 3.47% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Shell (SHEL) trades at $88.50, down 1.23% today, with a bullish technical signal from moving averages and neutral oscillators. Recent earnings beat expectations in Q1 and Q2 2026, driven by higher oil prices and operational gains. The company maintains strong cash flow, reduced debt, and a discounted valuation with a P/E of 9.79. Analysts show strong buy sentiment, with a consensus price target of $103.60, and recent news highlights strategic asset sales and investments in gas projects.
Outlook is positive with earnings momentum and shareholder returns via dividends and buybacks, but risks include oil price volatility and regulatory pressures. The stock offers value with upside potential, though investors should monitor commodity swings and geopolitical factors affecting energy markets.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2021, it produced 1.7 million barrels of liquids and 8.7 billion cubic feet of natural gas per day. At year-end 2021, reserves stood at 9.2 billion barrels of oil equivalent, 50% of which consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.8 mmb/d located in the Americas, Asia, Africa, and Europe and sells 15 mtpa of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
Read more on SHEL →